28 September 2026
South Africa's pharmaceutical policy must weigh low medicine prices against sustaining local manufacturing and supply security.
22 August 2026
Pharmaceutical localisation talks target pricing reform, investment incentives, medicine security and stronger local manufacturing.
7 August 2026
Local pharmaceutical manufacturing is under pressure as state tenders favour low prices, threatening jobs, medicine supply and investment.
24 July 2026
The Extensior launch in South Africa offers 15% lower semaglutide prices, but Discovery Health says scheme coverage is unlikely to expand.
8 April 2026
The 1.47% increase in medicine prices faces legal challenges, as manufacturers demand transparency and an urgent inflation-linked adjustment.